|
| Status |
Public on Nov 14, 2014 |
| Title |
Genome-wide map of H3K4me3 binding sites by ChIP-seq in human lymphoblastoid cell lines treated with doxorubicin |
| Organism |
Homo sapiens |
| Experiment type |
Genome binding/occupancy profiling by high throughput sequencing
|
| Summary |
We have used chromatin immune-precipitation with parallel sequencing (ChIP-Seq) technology to identify genome-wide H3K4me3 binding in human lymphoblastoid cell lines treated with a DNA-damaging chemotherapeutic reagent doxorubicin.
|
| |
|
| Overall design |
ChIP-Seq analysis of H3K4me3 binding sites in human lymphoblastoid cells treated with Doxorubicin or vehicle
|
| |
|
| Contributor(s) |
Su D, Wang X, Bell DA |
| Citation(s) |
25569532 |
| |
| Submission date |
Oct 25, 2013 |
| Last update date |
May 15, 2019 |
| Contact name |
Xuting Wang |
| E-mail(s) |
[email protected]
|
| Phone |
9842873840
|
| Organization name |
NIEHS/NIH
|
| Street address |
111 TW Alexander Dr
|
| City |
Research Triangle Park |
| State/province |
NC |
| ZIP/Postal code |
27709 |
| Country |
USA |
| |
|
| Platforms (1) |
| GPL9115 |
Illumina Genome Analyzer II (Homo sapiens) |
|
| Samples (2) |
|
| This SubSeries is part of SuperSeries: |
| GSE51714 |
p53 activation effect on GM12878 lymphoblastoid cells |
|
| Relations |
| BioProject |
PRJNA224699 |
| SRA |
SRP031909 |
